CORC

在结果中检索

CORC

浏览/检索结果: 共7条，第1-7条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
Discovery and development of pyrotinib: A novel irreversible EGFR/HER2 dual tyrosine kinase inhibitor with favorable safety profiles for the treatment of breast cancer 期刊论文
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 卷号: 110, 页码: 51-61
作者:  Li, Xin;  Yang, Changyong;  Wan, Hong;  Zhang, Ge;  Feng, Jun
收藏  |  浏览/下载：136/0  |  提交时间：2019/01/08
Targeting EGFR/HER2 heterodimerization with a novel anti-HER2 domain II/III antibody 期刊论文
MOLECULAR IMMUNOLOGY, 2017, 卷号: 87
作者:  Yu, Xiaojie;  Wang, Lingfei;  Shen, Yafeng;  Wang, Chao;  Zhang, Yajun
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05
Targeting EGFR/HER2 heterodimerization with a novel anti-HER2 domain II/III antibody 期刊论文
Molecular immunology, 2017, 卷号: 87, 页码: 300-307
作者:  Yu Xiaojie[1];  Wang Lingfei[2];  Shen Yafeng[3];  Wang Chao[4];  Zhang Yajun[5]
收藏  |  浏览/下载：12/0  |  提交时间：2019/04/26
一种靶向EGFR和HER2的双特异性抗体及其应用 专利
申请日期: 2017-01-01,
作者:  邵国建;  韩倩倩;  徐昌志;  周琴;  鲁亚芳
收藏  |  浏览/下载：4/0  |  提交时间：2019/04/19
Targeting EGFR/HER2 heterodimerization with a novel anti-HER2 domain II/III antibody 期刊论文
MOLECULAR IMMUNOLOGY, 2017, 卷号: 87
作者:  Yu, Xiaojie;  Wang, Lingfei;  Shen, Yafeng;  Wang, Chao;  Zhang, Yajun
收藏  |  浏览/下载：7/0  |  提交时间：2019/12/06
Phase I study of QLNC120, a novel EGFR and HER2 kinase inhibitor, in pre-treated patients with HER2-overexpressing advanced breast cancer 期刊论文
2017, 卷号: 8, 期号: 22, 页码: 36750-36760
作者:  Zhang Tongtong;  Li Qing;  Chen Shanshan;  Luo Yang;  Fan Ying
收藏  |  浏览/下载：2/0  |  提交时间：2020/01/04
Integration of Receptor Tyrosine Kinases Determines Sensitivity to PI3K alpha-selective Inhibitors in Breast Cancer 期刊论文
THERANOSTICS, 2017, 卷号: 7, 期号: 4, 页码: 974-986
作者:  Xu, Yi-chao;  Wang, Xiang;  Chen, Yi;  Chen, Si-meng;  Yang, Xin-ying
收藏  |  浏览/下载：15/0  |  提交时间：2019/01/08

©版权所有 ©2017 CSpace - Powered by CSpace